Clinical Conductor CTMS Updates Facilitate Advanced Research Connectivity and Collaboration
Clinical Conductor, the industry’s most collaborative CTMS, was recently fitted with new features and functionality that provide users with even more capability to connect with other research technologies and further collaborate with research partners to ensure clinical research success.
Clinical Conductor, the industry’s most collaborative CTMS, was recently fitted with new features and functionality that provide users with even more capability to connect with other research technologies and further collaborate with research partners to ensure clinical research success.
Clinical Conductor CTMS now contains advanced EMR integration technology, which allows for the seamless transition of patient demographic data from EMR technologies such as EPIC, Cerner, Allscripts and more, directly into Clinical Conductor. This integration, done via HL7, eliminates many of the operational inefficiencies and risks associated with duplicate data entry. What’s more, the HL7 EMR integration helps research organizations simplify their patient recruitment and enrollment.
Monitoring functionality has also seen updates with the latest Clinical Conductor release. Monitors now have more advanced scheduling capabilities that allow for more dynamic scheduling by displaying many pieces of essential information related to scheduling on-time monitoring visits, such as when locations were last visited. With this, monitors can have improved tracking of adverse events, serious adverse events and protocol deviations in Clinical Conductor. This gives monitors more freedom to quickly add Adverse Events to their trip report and pull in-depth details on any particular event at any time, and generate printer-friendly reports that consist of individually-selected sections of the trip report. From there, users can then aggregate trip reports and search for necessary information and quickly attain necessary information required to make decisions. What’s more, Clinical Conductor provides greater functionality for visit report queries. Now, users can query based on entire trip reports, a particular research site, a particular study, or many other variables.
The last major collaborative function of the new Clinical Conductor is SMS messaging for CTMS. This impactful feature gives research organizations the tools to vastly improve patient engagement and retention throughout their active studies. The SMS messaging feature can be set to send automatic visit reminders to patients, as well as messages to providers. What’s more, organizations can use SMS messaging to begin the pre-screening process when recruiting interested patients for a new study. The profound impact of SMS messaging via Clinical Conductor ensures fewer missed visits and prompt study completion, saving organizations time and money.
“The research industry is continuing the trend of substantial collaboration throughout the research process, but most CTMS providers lag in facilitating this collaboration,” stated Bio-Optronics President and CEO Dan Kerpelman. “The latest updates in SMS messaging, monitoring and EMR integration increase the already unparalleled depth of collaborative functionality only found in Clinical Conductor CTMS.”
About Clinical Conductor
Clinical Conductor is the industry’s first collaborative and configurable CTMS for organizations managing or executing clinical trials. Created by Bio-Optronics, an industry-leading provider of software and services to healthcare and life sciences organizations around the world, Clinical Conductor provides users with the specific features and functionality they need to effectively collaborate with or among sites and other partners, deliver high-quality research and maximize profitability. Used by over 1,700 organizations around the world, Clinical Conductor provides organizations with the tools they need to continue to raise the bar in clinical research. To learn more about Clinical Conductor CTMS please visit the Clinical Conductor CTMS page.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Phase III Trial Data Show Subcutaneous Pembrolizumab as Noninferior to IV Keytruda
March 31st 2025Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and treatment room time while maintaining efficacy and safety endpoints compared to intravenous Keytruda.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
